Happy report!4 companies in Changping District have been identified by Beijing Foreign Investment R & D Center

A few days ago, the results of the first batch of Beijing Foreign Investment R & D Center in 2022 were announced. A total of 29 companies were on the list. Four companies including Jianhua Pharmaceutical Technology Co., Ltd. and Vitamoron (Beijing) Biotechnology Co., Ltd. were approved.

In the laboratory of Beijing Nuo and Nord's Pharmaceutical Technology Co., Ltd. (hereinafter referred to as "Novo"), R & D personnel are conducting biological analysis. As a leader in the global diabetes treatment field, innovation is an important engine for Nuo and Nord to drive changes in the need for patients.

"Our strategic core includes the discovery and verification of drug targets, oral biopharmaceutical research and development, and cutting -edge drug discovery technology platforms. At the same time, we also actively carry out foreign cooperation and through scientific research institutes, hospitals and biotechnology companies, etc. Carry out cooperation to promote the transformation of innovative projects. "Han Dan, president of Beijing and Nord's Pharmaceutical Technology Co., Ltd., told reporters that the application for foreign -funded R & D centers hopes to be guided by the government, accelerate the process of innovation drug research and development, and benefit more patients around the world.

From leading diabetes treatment drugs to creating the first drug to treat obesity, to determination to defeat chronic diseases related to metabolism, and rare blood diseases and rare endocrine diseases that have not been met that they have not been met, Noord Nord is constantly exploring In the research and development of drugs in your focus, he spared no effort to help more patients help more patients.

According to Han Dan, in the research and development work, the Changping District Government provided strong support for enterprises. In April of this year, the company was included in the "Changping District Key Guarantee Enterprise" to ensure the normal operation of the company's epidemic. At the same time, Zhongguancun Customs Inspection Division is located in Zhongguancun Life Science Park, which provides convenience for the customs inspection of the company's research and development work. Customs implementing rapid labels on experimental mice, shortening the isolation period from 30 days to 14 days, greatly accelerating the company's research and development efficiency.

Next, the company will continue to introduce high -level R & D personnel, increase investment in scientific research, strive to build multiple new drug research and development technology platforms, better contribute to domestic and foreign biopharmaceutical research and development, and promote the construction of "two districts".

Also obtained by Beijing Foreign Investment R & D Center is also Bao Nuo Technology (Beijing) Co., Ltd. (hereinafter referred to as Bao Nuo Technology). As one of the top 10 R & D centers in Bao Nuo Sandia, Pajo Technology settled in Zhongguancun Life Science Park in 2006.

"The application for foreign -funded R & D centers also hopes to provide further policy convenience through its introduction in overseas talents, customs clearance, and foreign business exchanges, so as Shao Ning, Vice President of Operation, told reporters that Bao Nuo Technology has an experimental office area of ​​about 10,000 square meters, providing comprehensive integration services for major pharmaceutical companies, biomedical companies, and scientific research institutes around the world to support drug discovery, development and production. The company can not only help developers avoid the in -depth accumulation of laboratories, venues and talents required by the project, but also help developers to quickly deliver phased results at low cost and high efficiency.

Thanks to the foundation of R & D strength, Bao Nuo Technology, which has been established for 16 years, has deep and rich therapeutic professional knowledge in large and small molecules and patent technology platforms. From target discovery to the development of clinical phase and second phase of medication.

Since the establishment of Bao Nuo Technology, it has begun to lay out to recruit talents. The company currently has about 500 employees, and nearly 90%are highly educated researchers. Among them, middle and senior management personnel come from well -known pharmaceutical and biomedical companies at home and abroad, and have senior experience in developing new drugs.

"In recent years, the Changping District Government has given enterprises a lot of help in terms of talent introduction, talent guarantee, and funding subsidies." According to Shao Ning, the company also submitted the "Elimination of Import Equipment for Importing Equipment for Foreign R & D Center" to the District Commerce Bureau a few days ago. Once the application, once the review, this will bring great convenience to the company's import equipment tax and exemption, customs clearance, etc.

In recent years, the state has encouraged and promoted foreign investment, and it is one of the important ways to encourage foreign investors to invest in China. The "Regulations on the Establishment and Development of Foreign R & D Center in Beijing" (hereinafter referred to as the "Regulations") proposed that foreign research and development centers refer to all or parts of foreign investors investing in foreign investors abroad. The scope of business includes institutions that carry out research and development and experimental development (including intermediate tests for R & D activities) in the field of natural science and its related science and technology fields, including R & D and innovation centers and open innovation platforms.

Today, foreign research and development centers have gradually become a trend of international scientific and technological innovation cooperation. Next, Changping District will continue to grasp the construction of the two districts, do a good job in the application and service of foreign -funded research and development centers, and set up and establish a foreign -funded research and development center in Beijing in Beijing from the five major aspects of talent services, scientific research incentives, intellectual property rights, business environment, and territorial protection. Development provides support, helps more foreign research and development centers to obtain identification, and stimulate the vitality of urban innovation.

Photo/Shang Ying

---

- END -